Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Required knowledge for Henry Schein (HSIC) Investors

A strong performer from today's evening trading session is Henry Schein, whose shares rose 2.4% to $75.67 per share. For those of you thinking about investing in the stock, here is a brief value analysis of the stock using the company's basic fundamental ratios.

an Increase in Expected Earnings Improves Its Value Outlook but Priced at a Premium:

Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. The company belongs to the Health Care sector, which has an average price to earnings (P/E) ratio of 22.94 and an average price to book (P/B) ratio of 3.19. In contrast, Henry Schein has a trailing 12 month P/E ratio of 22.9 and a P/B ratio of 2.65.

Henry Schein's PEG ratio is 1.63, which shows that the stock is probably overvalued in terms of its estimated growth. For reference, a PEG ratio near or below 1 is a potential signal that a company is undervalued.

EPS Trend Sustained Primarily by Reducing the Number of Shares Outstanding:

2020 2021 2022 2023 2024 2025
Revenue (M) $10,119 $12,401 $12,647 $12,339 $12,673 $13,184
Gross Margins 28% 30% 30% 31% 32% 31%
Net Margins 4% 5% 4% 3% 3% 3%
Net Income (M) $404 $631 $566 $416 $390 $398
Net Interest Expense (M) $41 $27 $47 $87 $131 $150
Depreciation & Amort. (M) $64 $71 $68 $70 $83 $101
Diluted Shares (M) 143 142 138 132 128 122
Earnings Per Share $2.82 $4.45 $3.91 $3.16 $3.05 $3.27
EPS Growth n/a 57.8% -12.13% -19.18% -3.48% 7.21%
Avg. Price $62.01 $74.18 $82.4 $75.71 $68.89 $73.5
P/E Ratio 21.91 16.45 21.07 23.81 22.44 22.34
Free Cash Flow (M) $550 $631 $506 $353 $700 $573
CAPEX (M) $49 $79 $96 $147 $148 $139
EV / EBITDA 15.19 12.22 15.02 17.31 15.08 15.01
Total Debt (M) $626 $833 $1,052 $2,087 $1,886 $2,343
Net Debt / EBITDA 0.34 0.77 1.15 2.8 2.51 2.9
Current Ratio 1.66 1.67 1.79 1.67 1.42 1.38

Henry Schein has positive cash flows, just enough current assets to cover current liabilities, as shown by its current ratio of 1.38, and significant leverage levels. We also note that the company has growing revenues and increasing reinvestment in the business working in its favor. However, the firm suffers from slimmer gross margins than its peers and EPS growth achieved by reducing the number of outstanding shares.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS